1. American Academy of Audiology. (2009). Position statement and clinical practice guidelines: Ototoxicity monitoring [Online, verified 7/5/2016]. http://audiology-web.s3.amazonaws.com/migrated/OtoMonGuidelines.pdf_539974c40999c1.58842217.pdf .
2. American Speech-Language-Hearing Association. (1994). Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA, 36(Suppl. 12), 11–19.
3. Anderson, J. M., & Campbell, K. (2015). Assessment of interventions to prevent drug-induced hearing loss. In J. M. Miller, C. G. Le Prell, & L. P. Rybak (Eds.), Oxidative stress in applied basic research and clinical practice: Free radicals in ENT pathology (pp. 243–269). New York: Humana Press.
4. ANSI S3.6-1989, “American National Standard Specifications for Audiometers.”
5. Baguley, D., & Norman, M. (2001). Tinnitus handicap inventory. Journal of the American Academy of Audiology, 12(7), 379–380.